Jan 16, 2023 | Advocacy, Exercise, Featured, LOOPing, Research News, Technology Updates
CGM is BIG MONEY!!! How Abbott plans to make its Freestyle Libre a $10B product by Elise Reuter for MedTechDive.com, 10 January 2023. CEO Robert Ford discussed plans to grow the market for Abbott’s continuous glucose monitors and its broader diabetes...
Jan 9, 2023 | A Little Humor, Featured, Foods, Research News, Stories of D Life, Technology Updates, Videos
Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System in a press release on NewsWire.com, 4 January 2023. Caution: The iLet Bionic Pancreas is an investigational device...
Jan 2, 2023 | A Little Humor, Advocacy, Featured, Technology Updates
Novo Nordisk addresses off-label Ozempic use as it grapples with multiple shortages by Nicole DeFeudis for EndPoints.com, 13 December 2022. On the heels of Wegovy supply troubles, Novo Nordisk is reporting a shortage of its diabetes treatment Ozempic which contains...
Dec 19, 2022 | Featured, Research News, Technology Updates
Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market by Nick Paul Taylor for MedTechDive.com, 14 December 2022. Tandem Diabetes Care agreed to acquire Switzerland-based AMF Medical to gain its insulin pump patch technology. Tandem...
Dec 12, 2022 | Featured, Foods, Research News, Technology Updates
Progressive beta cell dysfunction may be primary driver of impaired glucose tolerance by Michael Monostra for Healio.com/endocrinology, 1 December 2022. Loss of beta cell function serves as the basis for progression from normal glucose tolerance to impaired glucose...
Dec 9, 2022 | Featured, Research News, Technology Updates
Dexcom G7 CGM System Receives FDA Clearance posted on EndocrinologyNetwork.com, 8 December 2022. Dexcom has announced their Dexcom G7 Continuous Glucose Monitoring (CGM) system has received clearance from the US Food and Drug Administration for people with all types...